CTIS2023-509399-40-00进行中（未招募）1 期
AN OPEN-LABEL, RANDOMIZED, SINGLE DOSE, TWO-STAGE CROSSOVER ADAPTIVE BIOEQUIVALENCE STUDY OF TRIAMCINOLONE ACETONIDE 40 MG/ML STERILE INJECTABLE SUSPENSION (Test product–Lisapharma S.p.A) VERSUS KENACORT® 40 MG/ML SUSPENSION (Reference product – Bristol Myers Squibb) AFTER INTRAMUSCULAR ADMINISTRATION TO HEALTHY VOLUNTEERS
aboratorio Italiano Biochimico Farmaceutico Lisapharma S.p.A.0 个研究点目标入组 30 人开始时间: 2023年11月28日最近更新:
适应症
试验速览
- 阶段
- 1 期
- 状态
- 进行中（未招募）
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 64（—）
- 性别
- All
入选标准
- 未提供
排除标准
- 未提供
研究者
相似试验
已完成
不适用
A SINGLE-DOSE, TWO-TREATMENT, TWO-PERIOD STUDY OF TWO DIFFERENT FORMULATONS OF CURCUMIN 10 MG ORALLY SOLUBLE TABLET AND CURCUNEX G 5 Mg IN HEALTHY, ADULT, HUMAN, MALE SUBJECTS UNDER FASTING CONDITIONS.CTRI/2021/03/031895KMS Health Center Pvt Ltd3
已完成
不适用
AN OPEN-LABEL, RANDOMIZED, SINGLE DOSE, TWO-TREATMENT (FED VS FASTING), TWO-PERIOD, TWO-SEQUENCE CROSSOVER STUDY TO ASSESS THE EFFECT OF FOOD ON SODIUM OXYBATE FOR EXTENDED RELEASE ORAL SUPENSION (FT218) FORMULATION ADMINISTRERED AT 6 G IN HEALTHY VOLUNTEERSNL-OMON44554Flamel Ireland Limited (Ltd) trading under the business name Avadel Ireland16
已完成
Unknown
Phase 1 study to evaluate the safety and pharmacokinetics comparison of AD-104 in healthy adult volunteersKCT0009332Addpharma40
已完成
不适用
A RANDOMIZED, TWO-PERIOD, OPEN-LABEL, SINGLE DOSE CROSSOVER STUDY TO EVALUATE THE BIOEQUIVALENCE OF AQX-1125 IMMEDIATE RELEASE TABLETS AND CAPSULES IN HEALTHY VOLUNTEERSInterstitial Cystitis/Bladder Pain Syndrome (IC/BPS)10004994NL-OMON42576Aquinox Pharmaceuticals (Canada) Inc.18
已完成
不适用
Pharmacokinetic study of SPARC1613 and Reference1613CTRI/2016/12/007565Sun Pharma Advanced Research Company Limited142